| Product NDC: | 68094-316 |
| Proprietary Name: | Ranitidine Hydrochloride |
| Non Proprietary Name: | Ranitidine Hydrochloride |
| Active Ingredient(s): | 15 mg/mL & nbsp; Ranitidine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68094-316 |
| Labeler Name: | Precision Dose Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078312 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110425 |
| Package NDC: | 68094-316-58 |
| Package Description: | 50 BAG in 1 CASE (68094-316-58) > 1 SYRINGE, PLASTIC in 1 BAG > 1 mL in 1 SYRINGE, PLASTIC |
| NDC Code | 68094-316-58 |
| Proprietary Name | Ranitidine Hydrochloride |
| Package Description | 50 BAG in 1 CASE (68094-316-58) > 1 SYRINGE, PLASTIC in 1 BAG > 1 mL in 1 SYRINGE, PLASTIC |
| Product NDC | 68094-316 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ranitidine Hydrochloride |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20110425 |
| Marketing Category Name | ANDA |
| Labeler Name | Precision Dose Inc. |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |